Grant: Doctoral Award: Doctoral Foreign Study Award (DFSA)
Direct Payment
$105,000.00
Profiling T cell cross-reactivity in elite HIV controllers
EF 2020-21
Résumé
'Elite controllers' are individuals infected with HIV who develop natural immunity that delays or prevents disease altogether. Elite controller immune responses seem to be resistant to frequent mutations of the virus. Prior studies suggest a reason: key immune cells known as T cells may recognize multiple parts of the HIV virus rather than one. Existing technology is unable to find these 'cross-reactive' T cells and match them to parts of the HIV virus. My project proposes a new method to determine the targets and cross-reactivity of T cells on a significantly larger scale than previously possible. Using this tool, I will examine the T cells of HIV elite controllers and patients who require treatment. If successful, this project will help to resolve a long-standing debate: do T cells in elite controllers target parts of the HIV virus in meaningfully different ways? If so, this information could be applied to vaccines and therapeutics to generate 'elite controller'-type immune responses in other HIV-infected individuals.
Programme
Doctoral Award: Doctoral Foreign Study Award (DFSA)
Bénéficiaire
Emplacement
Massachusetts, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
436960
Name
Gaglione Stephanie A
Region
Massachusetts
Country
United States of America
Orgtype
Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Profiling T cell cross-reactivity in elite HIV controllers
Programtype2
Studentship Programs
Orgnameinp2
Direct Payment
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award: Doctoral Foreign Study Award (DFSA)
Keyworddelim
Cd8+ T Cell Immunity; Hiv; Lentivirus; T Cell Antigen Discovery; T Cell Receptor; Tcr-Pmhc Interactions
Abstract
'Elite controllers' are individuals infected with HIV who develop natural immunity that delays or prevents disease altogether. Elite controller immune responses seem to be resistant to frequent mutations of the virus. Prior studies suggest a reason: key immune cells known as T cells may recognize multiple parts of the HIV virus rather than one. Existing technology is unable to find these 'cross-reactive' T cells and match them to parts of the HIV virus. My project proposes a new method to determine the targets and cross-reactivity of T cells on a significantly larger scale than previously possible. Using this tool, I will examine the T cells of HIV elite controllers and patients who require treatment. If successful, this project will help to resolve a long-standing debate: do T cells in elite controllers target parts of the HIV virus in meaningfully different ways? If so, this information could be applied to vaccines and therapeutics to generate 'elite controller'-type immune responses in other HIV-infected individuals.
Competitiondate
202010
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Gaglione, Stephanie A
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~